Study identifies perception gap in incidence, impact of CINV/RINV
the ONA take:
There is a perpetual gap between healthcare professionals and patient perceptions of incidence and impact on patients' daily life of chemotherapy- and radiotherapy-induced nausea and vomiting (CINV/RINV), according to findings presented at the joint Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO) 2015 Annual Meeting on Supportive Care in Cancer in Copenhagen, Denmark.
Researchers found that oncologists and oncology nurses overestimate the incidence of CINV/RINV, but underestimate the effect that CINV/RINV has on patients' daily lives. Moreover, data showed that 28% of patients believe oncologists underestimate the impact of CINV/RINV on patients' daily lives.
Results also showed that physicians and nurses believe 60% of patients are fully compliant with physicians' and/or nurses guidelines for self-administration of anti-emetic medications; however, only 38% reported full compliance. Patients reported reluctance to increase pill burden and concern that swallowing would cause nausea/vomiting as reasons for non-compliance.
The findings suggest that the gap between physician and patient perceptions may result in inadequate management of patients' CINV/RINV.
There is a perpetual gap between healthcare professionals and patient perceptions of incidence and impact on patients' daily life of CINV/RINV.
Sign Up for Free e-newsletters
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- Age Not a Deterrent to Immunotherapy for Malignant Melanoma
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|